Search
for
Sort by
Research 301–330 of 1000+
- Clinical Aspects and Spectrum of Illness of TSS: Overview
- Tumour regression predicts higher risk of sentinel node involvement in thin cutaneous melanomas
- THE DISEASE SPECTRUM, EPIDEMIOLOGY, AND ETIOLOGY OF TOXIC-SHOCK SYNDROME
- Primary cicatricial alopecia
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Hair and scalp disorders in ethnic populations
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Oral Retinoids in Dermatology
- Oral Manifestations of Hematologic and Nutritional Diseases
- Skin Conditions in Figure Skaters, Ice-Hockey Players and Speed Skaters
- Adverse Cutaneous Reactions to Mood Stabilizers
- Types of Hair Loss and Treatment Options, Including the Novel Low-Level Light Therapy and Its Proposed Mechanism
- Adverse Cutaneous Reactions to Antidepressants
- Psychocutaneous disease
- Toxic shock syndrome: Recent developments in pathogenesis
- CLINICAL AND LABORATORY EVALUATION OF AIDS TRICHOPATHY
- Hypersensitivity Reactions to Anticoagulant Drugs
- Clinical management of cutaneous adverse events in patients on targeted anticancer therapies and immunotherapies: a national consensus statement by the Spanish Academy of Dermatology and Venereology and the Spanish Society of Medical Oncology
- Adverse Drug Reactions in HIV/AIDS Patients on Highly Active Antiretro Viral Therapy: A Review of Prevalence
- Skin disease in pregnancy
- Case Report: Pityriasis Rosea-Like Eruption Following COVID-19 Vaccination
- Cicatricial alopecia
- Dermatological Manifestations of Stress in Normal and Psychiatric Populations
- Contraception and the dermatologist
- Exfoliative cutaneous lupus erythematosus in German shorthaired pointer dogs: disease development, progression and evaluation of three immunomodulatory drugs (ciclosporin, hydroxychloroquine, and adalimumab) in a controlled environment
- Systemic causes of hair loss
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Adverse cutaneous reactions to chemotherapeutic agents and cytokine therapy
- Pegylated-interferon-α<sub>2a</sub>in clinical practice: how to manage patients suffering from side effects
- Dermatologic Problems of Older Women